A detailed history of Ayal Capital Advisors LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ayal Capital Advisors LTD holds 13,600 shares of BIO stock, worth $3.31 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
13,600
Holding current value
$3.31 Million
% of portfolio
1.28%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$313.15 - $374.28 $4.26 Million - $5.09 Million
13,600 New
13,600 $4.47 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ayal Capital Advisors LTD Portfolio

Follow Ayal Capital Advisors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayal Capital Advisors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ayal Capital Advisors LTD with notifications on news.